BSE Live
Oct 08, 10:52Prev. Close
505.65
Open Price
507.10
Bid Price (Qty.)
505.20 (5)
Offer Price (Qty.)
506.25 (5)
NSE Live
Oct 08, 10:52Prev. Close
506.40
Open Price
509.80
Bid Price (Qty.)
505.70 (2)
Offer Price (Qty.)
506.00 (75)
Cash Flow of Aarti Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 185.29 | 131.02 | 124.50 | 116.01 | 95.09 | |
Net CashFlow From Operating Activities | 250.74 | 143.09 | 69.77 | 174.75 | 133.29 | |
Net Cash Used In Investing Activities | -33.21 | -61.67 | -73.54 | -106.98 | -98.79 | |
Net Cash Used From Financing Activities | -215.41 | -80.07 | 3.92 | -68.23 | -33.26 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 2.13 | 1.35 | 0.15 | -0.45 | 1.24 | |
Cash And Cash Equivalents Begin of Year | 4.64 | 3.29 | 3.15 | 3.60 | 3.58 | |
Cash And Cash Equivalents End Of Year | 6.77 | 4.64 | 3.29 | 3.15 | 4.82 |
21.07.2025
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y
07.05.2025